Exhibitions and events

List of headings :

OncoTarget : signature of the exclusive licence - 23.05.2023
  Personalised medicine • Oncology • Next-generation sequencing-NGS • Diagnostic • • Biotechnology • Bioinformatics • Innovation • Technology transfer   

Mini exhibition at the MRC Toxicology UNIT
25th January 2023

Forum LABO Paris 2023
From 28 to 30/03/2023 - Paris expo Porte de Versailles, Paris, France

November 16-17-18, 2022 - Venice- Italy 

Launch of ONCOG clinical trial
Inclusion of the First Patient in the ONCOG Clinical Study for Personalized Treatment of Metastatic Colorectal Cancer Using Oncogramme®     09-19-2023    

10th ESE Young Endocrinologists & Scientists (EYES) Meeting
 8-10 September 2023 - Würzburg - Germany

Histologica
28 - 29 Apr 2023 - Oberhausen -Germany 

74th Mosbacher Kolloquium
23-25 March 2023-Mosbach-Germany

8th German Pharm-Tox Summit
6-9 March 2023-ULM-Germany 

5th Brainstorming Research Assembly for Young Neuroscientists (BraYn)
28-29-30 September- 2022, Rome

8th International Tuebingen Symposium on Pediatric Solid Tumours
December 9-10, 2022, Tuebingen – Germany

Expression, purification and characterization of membrane proteins (mPEPC2)
September 5 - 12, 2022 in Hamburg, Germany  

10th Conference of the German Stem Cell Network
September 13 - 16, 2022 - Halle Münsterland -  Münster - Germany

The International Fall Meeting of the German Society for Biochemistry and Molecular Biology (GBM)
14-16 September 2022, Heinrich Heine University Düsseldorf - Germany

23rd Bamberg Morphological Days
28 - 30 January 2022 - Bamberg - Germany

Neurizons 2022
7-10 June 2022 - Göttingen

Histologica 2022
20-21 May 2022 - Oberhausen

Workshop IIS-CED 2022
5-6 May 2022 - Bad Soden

Press release : Oncomedics joins CliniSciences Group
CliniSciences Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.

Press release : New biomarker for diagnosing triple negative breast cancer
Joint efforts between Biotrend, Erganeo and the academic lab headed by Véronique Baud, in the field of research to facilitate the diagnosis of triple negative breast cancer have yielded new findings that make it easier to classify and predict degree of aggressiveness.

Discover our 2022 calendar and receive a gift
Our new 2022 calendar is now available, and it will surprise you